PURE Bioscience, Inc. (PURE)

0.09 +28.57% (+0.02)

Over 5Y: -75.7%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

0.2 0.4
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '21 — Revenue: 859K Q4 '21 — Operating Cash Flow: -412K Q4 '21 — Free Cash Flow: -429K Q4 '21 — Net Income: -733K Q1 '22 — Revenue: 501K Q1 '22 — Operating Cash Flow: -576K Q1 '22 — Free Cash Flow: -630K Q1 '22 — Net Income: -796K Q2 '22 — Revenue: 416K Q2 '22 — Operating Cash Flow: -630K Q2 '22 — Free Cash Flow: -631K Q2 '22 — Net Income: -702K Q3 '22 — Revenue: 524K Q3 '22 — Operating Cash Flow: -609K Q3 '22 — Free Cash Flow: -620K Q3 '22 — Net Income: -760K Q4 '22 — Revenue: 412K Q4 '22 — Operating Cash Flow: -603K Q4 '22 — Free Cash Flow: -620K Q4 '22 — Net Income: -1.2M Q1 '23 — Revenue: 471K Q1 '23 — Operating Cash Flow: -902K Q1 '23 — Free Cash Flow: -939K Q1 '23 — Net Income: -993K Q2 '23 — Revenue: 397K Q2 '23 — Operating Cash Flow: -967K Q2 '23 — Free Cash Flow: -967K Q2 '23 — Net Income: -1.1M Q3 '23 — Revenue: 407K Q3 '23 — Operating Cash Flow: -665K Q3 '23 — Free Cash Flow: -704K Q3 '23 — Net Income: -876K Q4 '23 — Revenue: 602K Q4 '23 — Operating Cash Flow: -744K Q4 '23 — Free Cash Flow: -787K Q4 '23 — Net Income: -1M Q1 '24 — Revenue: 722K Q1 '24 — Operating Cash Flow: -440K Q1 '24 — Net Income: -735K Q2 '24 — Revenue: 326K Q2 '24 — Operating Cash Flow: -883K Q2 '24 — Net Income: -1M Q3 '24 — Revenue: 441K Q3 '24 — Operating Cash Flow: -615K Q3 '24 — Net Income: -857K Q4 '24 — Revenue: 474K Q4 '24 — Operating Cash Flow: -593K Q4 '24 — Net Income: -756K Q1 '25 — Revenue: 556K Q1 '25 — Operating Cash Flow: -503K Q1 '25 — Net Income: -689K Q2 '25 — Revenue: 391K Q2 '25 — Operating Cash Flow: -544K Q2 '25 — Net Income: -798K Q3 '25 — Revenue: 491K Q3 '25 — Operating Cash Flow: -512K Q3 '25 — Net Income: -580K Q4 '25 — Revenue: 764K Q4 '25 — Operating Cash Flow: -456K Q4 '25 — Net Income: -332K Q1 '26 — Revenue: 708K Q1 '26 — Operating Cash Flow: -250K Q1 '26 — Net Income: -464K Q2 '26 — Revenue: 444K Q2 '26 — Operating Cash Flow: -606K Q2 '26 — Net Income: -785K Q3 '26 — Revenue: 506K Q3 '26 — Operating Cash Flow: -468K Q3 '26 — Net Income: -624K -1M -500K 0 500K 1M
Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-04-30, reported in USD. The newest fact in the filings is dated 2026-04-30, 122 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.4
OE margin -80.8%
Oper. margin -79.1%
Accruals -27.3%
Gross margin 58.8%
EBITDA margin -79.0%
FCF margin -73.5%
OCF margin -73.5%
Profit margin -91.0%
ROA -141.5%
Capex / sales —
OCF / EBIT —
ROCE —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.2
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.42×
Cash / Debt 0.36×
F-score 4.5 pts
Quick ratio 0.36×
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.8
Sales/sh Y/Y +26.7%
Sales CAGR 4Y -13.5%
Shares change +0.0057%
Sales Q/Q +3.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.